Wednesday, May 21, 2025
1:00 PM ET | 10:00 AM PT | 6:00 PM BST
In the first 100 days of the Trump administration, healthcare has shifted, as HHS Secretary Robert F. Kennedy Jr promotes the "Make America Healthy Again" (MAHA) agenda, DOGE cuts the workforce, and Medicaid and Medicare priorities are redefined. Where do stakeholders position themselves, and what crucial aspects should they actively monitor?
Join the Washington Analysis, A CFRA Business, Healthcare team for a roundtable discussion to explore key issues impacting the healthcare industry. They will examine the impact of recent leadership changes and restructuring at federal health agencies on regulation, stability, and workforce morale.
In this session, we will discuss:
- Congressional Outlook on Medicare Advantage, Medicare reimbursement (from the doc fix to site neutral), healthcare REITs, pharmacy benefit managers, pharmacies and drug pricing reform
- Medicaid: Examine how Medicaid reform proposals will disproportionately affects specific facilities, insurers and technology providers
- Medicare: Following the release of five proposed and two final payment rules, how will reimbursement to facilities (Acute Care, Long Term Care Hospitals, Home Health, SNFs, Hospice) and insurers CHANGE
- Pharmaceuticals & MedTech: Outlook for tariffs, vaccines, reduction in funding for biomedical research, shakeup at the FDA, DTC Ads, reimbursement expectations for 2026
- Workforce Reduction: Highlight topics such as the impact of DOGE-related cuts on health agencies
Speakers
John Sonsalla - Moderator
Head, Policy & Legal Research and Senior Financial Services Analyst
John Sonsalla joined Washington Analysis in 2022 as Head of Strategy and Senior Financial Services Analyst, where he covers banking, payments, fintech, cryptocurrency, loan servicing, credit ratings, capital markets, housing, and higher education, among other issues. Previously, he worked in the Investment Banking and Capital Markets Division of Credit Suisse.
Before working in finance, John held numerous roles at Brownstein Hyatt Farber Schreck, one of the nation’s leading multi-client government relations firms, where he worked with an array of Fortune 500 corporations, investment firms, national trade associations, and nonprofit institutions. He also spent time in the office of Congressman Joe Sestak, the House Committee on Energy and Commerce, and a national trade association.
John has worked on and managed campaigns and party conventions at the federal, state, and local level. John received his MBA from The Wharton School at the University of Pennsylvania and his B.A. from the School of Public Affairs at American University.
Tatiana Brown Johnson
SVP- Healthcare
Tatiana is a health policy expert with extensive experience in policy analysis and legislative strategy, joining Washington Analysis from a market-focused policy research firm. Her coverage includes hospitals, providers, facilities, Medicaid and Congressional issues. She previously worked as a senior health policy analyst at Centene, focusing on federal and state issues such as Medicare, Medicaid, and social determinants of health. Her career includes roles as a legislative director at Polsinelli and as a legislative aide to Senator Joe Donnelly on Capitol Hill. Tatiana also contributed to presidential and statewide political campaigns, enhancing her policy insights and strategy skills. She holds a master’s degree in health law and policy from Hofstra University.
Dr. Monet Stanford, PharmD
SVP-Healthcare
Monet is an expert in access and reimbursement policy, recently joining Washington Analysis from the Alliance for Regenerative Medicine, where she directed policy efforts for the cell and gene therapy sector. She covers life sciences, medical devices, prescription drug plans, health savings accounts and CMS/FDA issues. Previously, Monet led policy for the Association for Accessible Medicines, advocating for the generic and biosimilars industries, and managed government relations at Kaiser Permanente, utilizing data insights to inform regulatory engagement. She has also held policy roles at Centene and the National Association of Chain Drug Stores. Monet earned her Doctor of Pharmacy from the University of Maryland, with clinical training through a residency at Purdue University.
Laura Hobbs
SVP-Healthcare
Laura focuses on healthcare policy issues impacting the U.S. drug supply chain (insurers, pharmacy benefit managers and manufacturers), Medicare Parts B and D, Medicaid, and general health policy. Most recently, Laura was the Director of Health Care Policy at the American Action Forum. She also held policy roles with two large pharmacy benefit managers (PBMs) as well with the Pharmaceutical Care Management Association.
Laura also led several health policy focused projects for private equity firms at Capstone, a policy and regulatory due diligence firm. Early in her career, she served in three professional offices in the House of Representatives. Laura holds an MA in the History of Medicine from the University College London and a BA in History from American University.
Ryan Visnovec
Senior Research Associate
Ryan Visnovec joined Washington Analysis in 2021 as a Healthcare Research Associate, where he works across sectors, including financial services, healthcare, defense, and telecommunications. Prior to joining the firm, Ryan gained experience at the Hall Street Fund and The Stillman Exchange. Ryan graduated from Seton Hall University with a B.S. of Science, Finance, Spanish, and Journalism.
